Melanoma | Tumor

Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma

November 14th 2024, 4:00pm

Video

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.

TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in Melanoma

November 13th 2024, 2:00pm

Video

An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.

Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma

October 31st 2024, 7:00pm

Article

Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.

Longer Time Until Recurrence Associated With Better Melanoma Outcomes

October 2nd 2024, 1:00pm

Article

An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved progression and survival.

Long-Term Study Data Support Keytruda as Standard of Care for Advanced Melanoma

October 1st 2024, 9:00pm

Article

Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.

Oncology Drugs Approved by the FDA in September 2024

October 1st 2024, 3:00pm

Article

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.

Survival Benefit Continues at 10 Years From Opdivo Either Alone or With Yervoy in Advanced Melanoma

September 25th 2024, 1:00pm

Article

Findings from the CheckMate 067 of patients with advanced melanoma include the longest follow-up of a checkpoint inhibitor in any tumor type.

FDA to Speed Up Review of IBI363 for Advanced Melanoma

September 5th 2024, 3:00pm

Article

The Food and Drug Administration granted a fast track designation to IBI363 for patients with unresectable advanced or metastatic melanoma.

Immunotherapy Combination Elicit Waves of Response in Advanced Melanoma

September 4th 2024, 9:00pm

Article

A new algorithm has found that combining immune checkpoint inhibitors bolsters immune response among some patients with advanced melanoma.

Cancer Vaccine for NSCLC and Melanoma Could Be Paradigm-Changing

August 8th 2024, 2:01pm

Article

The cancer vaccine, mRNA-4157, garnered immune responses of 30 weeks among some patients with melanoma and lung cancer, study results showed.